Bluejay Diagnostics

Historical price data

Bluejay Diagnostics is a clinical-stage, pre-revenue company focused on revolutionizing point-of-care diagnostics with its automated Symphony platform. Its core mission is to accelerate clinical decision-making by providing quantitative biomarker results at the bedside within 20 minutes, directly addressing critical delays in conditions like sepsis. The company's near-term strategy is singularly focused on achieving regulatory clearance and commercialization of its lead Symphony IL-6 assay for sepsis triage. Long-term success hinges on leveraging the adaptable Symphony platform to develop a menu of follow-on assays, though it faces significant challenges including regulatory hurdles, commercialization execution, and intense competition in the diagnostics space.

The Symphony platform is an automated, portable, cartridge-based diagnostic system designed to deliver quantitative, laboratory-comparable results from a small blood sample in approximately 20 minutes at the point of care.